Joakim Nordanstig: SWEDEPAD Data Show Early Risk Of Limb Loss With Paclitaxel-Coated Devices
Joakim Nordanstig, President at Swedish Society for Vascular Surgery (SSVS), shared a post on LinkedIn:
”Very honoured to have been invited to the absolutely amazing Charing Cross Vascular and Endovascular Consensus Meeting in London this week.
Today, we provided data updates from the SWEDEPAD trials, including a detailed subgroup analysis in Rutherford 5-6 patients from SWEDEPAD 1, demonstrating an increased early risk for limb loss in patients treated with paclitaxel-coated devices compared to uncoated devices.
This observation may explain to overall neutral results in terms of major amputation rates (the primary endpoint) previously reported from SWEDEPAD 1. My colleague (dr Mårten Falkenberg) also presented important cause-specific mortality rate data from both SWEDEPAD 1 and 2 in an effort to better understand the late mortality signal noted with paclitaxel-coated devices.
We also presented vessel segment-specific data, showing that the previously reported reduced TVR rates with paclitaxel-coated devices was mainly driven by interventions in the femoropopliteal segment, whereas results were neutral infrapopliteally.”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support